Michael Ferguson, MD
Interventional Cardiology · Concord, NHNPI 1033189899
Payments from drug & device makers
What this record shows
12 manufacturers reported payments, led by BD at 54.7% of the total. Reporting peaked in 2021 at $2,740 and has fallen 87.6% since, to $339 in 2025. That places this record below the midpoint for interventional cardiology clinicians in NH, where the typical reported total is $5,309.
Across 48 payments — averaging $93.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- BD$2K
- Edwards Lifesciences$595
- Abiomed$521
- Abbott$417
- Cardiovascular Systems Inc.$118
- Shockwave Medical, Inc$101
- plus $276 from 6 others
What the payments were for
- Speaking & faculty fees$2,45055%
- Food & beverage$2,02745%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| BD | 1 | $2,450 |
| Edwards Lifesciences | 10 | $595 |
| Abiomed | 9 | $521 |
| Abbott | 14 | $417 |
| Cardiovascular Systems Inc. | 1 | $118 |
| Shockwave Medical, Inc | 3 | $101 |
| Boston Scientific | 3 | $99 |
| Philips North America LLC | 1 | $59 |
| Opsens Inc. | 2 | $46 |
| Terumo Medical Corporation | 1 | $32 |
| Cardiva Medical, Inc. | 2 | $28 |
| Chiesi USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LUTONIX$2,450
- Impella$356
- Diamondback Coronary$118
How this compares
$4,477 in reported general payments places this provider in the 45th percentile of 26 interventional cardiology providers in New Hampshire.
See all interventional cardiology providers in New Hampshire →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 33 | $40,122 |
| EntrestoSacubitril/Valsartan | 16 | $16,008 |
| Metoprolol Succinate | 81 | $861 |
| Metoprolol Tartrate | 83 | $812 |
| Atorvastatin Calcium | 66 | $492 |
| Torsemide | 18 | $372 |
| Rosuvastatin Calcium | 38 | $316 |
| Warfarin Sodium | 17 | $268 |
| Nitroglycerin | 33 | $263 |
| ClopidogrelClopidogrel Bisulfate | 38 | $227 |
| Carvedilol | 32 | $187 |
| Spironolactone | 24 | $151 |
| Losartan Potassium | 29 | $148 |
| Amlodipine Besylate | 45 | $147 |
| Furosemide | 46 | $142 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Concord
- Shahab MoossaviConcord$36K
- Augustin DelagoConcord$7K
- Matthew GibbConcord$4K
- Patrick MagnusConcord$2K
- Nitish SharmaDover$23K
- Rodrigo Mendirichaga MaganaDover$21K
- Hannah ChaudryLebanon$20K
- Eric RothsteinLebanon$20K
- James DevriesLebanon$19K
- Xiaoyu Yang-GiulianoManchester$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.